These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2469589)

  • 1. Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up.
    Hansen SW; Groth S; Sørensen PG; Rossing N; Rørth M
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):733-6. PubMed ID: 2469589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
    Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
    Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
    Sørensen PG; Rossing N; Rørth M
    Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin.
    Lehne G; Johansen B; Fosså SD
    Br J Cancer; 1993 Sep; 68(3):555-8. PubMed ID: 7688978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of corticosteroid administration on bleomycin lung toxicity.
    Jensen JL; Goel R; Venner PM
    Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
    Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
    J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.
    Petersen PM; Hansen SW
    Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
    Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
    Br J Cancer; 1995 Jan; 71(1):120-3. PubMed ID: 7529523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary.
    Taylor MH; Depetrillo AD; Turner AR
    Cancer; 1985 Sep; 56(6):1341-9. PubMed ID: 2411377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
    Hansen SW; Berthelsen JG; von der Maase H
    J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
    Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
    Blayney DW; Goldberg DA; Leong LA; Margolin KA; Burke JS; Doroshow JH
    Cancer; 1993 Apr; 71(7):2351-7. PubMed ID: 7680946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: an update.
    Willemse PH; Aalders JG; Bouma J; Mulder NH; Verschueren RC; de Vries EG; Sleijfer DT
    Gynecol Oncol; 1987 Nov; 28(3):268-77. PubMed ID: 2445635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Thomson D; Bishop J; Raghavan D; Tattersall M; Byrne M; Gill G; Harvey V; Snyder R; Dalley D
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1073-7. PubMed ID: 2474445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
    Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
    J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of chemotherapy in patients with testicular cancer.
    Osanto S; Bukman A; Van Hoek F; Sterk PJ; De Laat JA; Hermans J
    J Clin Oncol; 1992 Apr; 10(4):574-9. PubMed ID: 1372350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.